To make copycat drugs more competitive, FDA is taking a harder look at the originals

To make copycat drugs more competitive, FDA is taking a harder look at the originals  CNBC FDA's Gottlieb eyes PBM consolidation impact on generic entry: CNBC  Reuters In bid to lower prices, Gottlieb says FDA will take new action to speed approval of biosimilars  STATFull coverage

Read More ...
To make copycat drugs more competitive, FDA is taking a harder look at the originals published March 28, 2018 at 08:51PM. Original Source Link : https://www.cnbc.com/2018/03/28/to-make-biosimilars-more-competitive-fda-takes-harder-look-at-the-originals.html

loading...